Psychopathological and psychosocial assessment Mental health issues and psychological distress are frequently comorbid with ED [361]
Do not assume purity certificates prove suitability for injection
New York, NY: Humana Press (2014)
The article reflects information available as of June 2026 - a point in time when the compounded GLP-1 telehealth market is active and competitive, FDA enforcement discretion policy on compounded semaglutide and tirzepatide is subject to ongoing regulatory guidance, and the broader clinical evidence base for GLP-1 receptor agonists continues to expand through newly published long-term follow-up studies
In 2019, the Federal Court fined one company, Peptide Clinics, A$10 million for advertising prescription peptides to the public
Ongoing Clinical Trials Numerous questions remain under investigation, including: Long-term biological effects Extended safety profiles Pharmacodynamic characteristics Receptor-level adaptations Combination therapy applications As a result, ongoing clinical trials continue to generate new information regarding the compounds biological activity and potential future applications
